We are interested in novel targets, innovative compounds and
technologies that address unmet medical needs, and have the potential
to be disease modifying, for people living with a serious chronic
Partnerships based on long-term commitment and mutual interest, and open innovation platforms that share knowledge and data, are key to fostering this innovation.
From universities and biotech companies worldwide, to individual scientists and entrepreneurs, our ability to meet our goals depends on working with you.
Millions of people living with a serious chronic disease relying on us.